TGP

TPG is a leading global alternative asset manager that operates a significant healthcare and life sciences investment franchise. Through specialized platforms such as TPG Biotech, TPG Healthcare Partners (THP), and TPG Life Sciences Innovations (LSI), the firm invests across the entire healthcare spectrum, from early-stage drug discovery and preclinical biotech to large-cap healthcare services and delivery models. TPG's life sciences strategy focuses on advancing breakthrough technologies to clinical proof-of-concept, particularly in therapeutic areas like oncology, rare diseases, and immunology. The firm has deployed over $30 billion across the global healthcare ecosystem since 2003, supporting a diverse portfolio of innovative companies including Bicara Therapeutics, Sionna Therapeutics, and LifeStance Health.